Purpose: To determine the diagnostic value of pleural fluid telomerase
activity in distinguishing a malignant from a nonmalignant pleural ef
fusion in a cohort of patients undergoing thoracentesis. Patients and
Methods: Using ct polymerase chain reaction (PCR)-based assay, telomer
ase activity was examined in the pleural fluid cells obtained from 144
consecutive, unselected patients. According to the final diagnosis ac
hieved, these patients were classified into three groups: group I cons
isted of 70 malignant pleural effusions diagnosed by either fluid cyto
logy or pleural biopsy, group II consisted of 52 nonmalignant pleural
effusions, and another 22 samples were categorized to be suspicious ma
lignant pleural effusions (group III) due to inconclusive results in e
ffusion cytology and percutaneous pleural biopsy, but were strongly su
spicious in clinical settings. Results: The presence of telomerase act
ivity was observed in 64 of 70 samples in group I (91.4%), three of 52
samples in group II (5.8%), and 20 of 22 samples in group III. All th
ree nonmalignant, telomerase-positive pleural effusion samples in grou
p II were obtained from patients with tuberculosis. As a diagnostic cr
iterion for malignant pleural effusion in group I and group II patient
s, positive telomerase activity had a sensitivity of 91.4%, a specific
ity of 94.2%, and a positive and negative predictive value of 0.96 and
0.89, respectively. Conclusion: Our results indicate that the detecti
on of telomerase activity may be a useful adjunct to cytopathologic me
thods in the diagnosis of malignant pleural effusions. (C) 1998 by Ame
rican Society of Clinical Oncology.